Bristol-Myers Squibb Company Ce (CELG-RI) Stock Ticker
CELG-RI right now
Market factors today
Unlock the full CELG-RI picture
About Bristol-Myers Squibb Company Ce
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
CELG-RI stock facts
| Ticker symbol | CELG-RI |
| Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $223.5M |
| CEO | Christopher S. Boerner |
| Employees | 34,100 |
| Headquarters | Princeton, NJ, US |
| IPO date | 2019-11-21 |
| Website | www.bms.com |
What you can see for CELG-RI on Tickr
Live CELG-RI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CELG-RI report.
Rankings
CELG-RI peers
FAQ
What is the ticker symbol for Bristol-Myers Squibb Company Ce?
The ticker symbol for Bristol-Myers Squibb Company Ce is CELG-RI, listed on the New York Stock Exchange.
What is CELG-RI?
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor…